Across TCGA patient cohorts, CDY22P RNA expression is significantly associated with the mutation status of many other genes, with 33 significant associations in total. BRCA shows the largest number of these associations.

The most reproducible CDY22P-associated genes across cancer lineages are PDYN, NOP56, and ASPN. Each is linked with CDY22P in more than 1 cancer types. Because this analysis shows association rather than direction, both CDY22P-to-partner and partner-to-CDY22P results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CDY22P→partner) and Y-score (partner→CDY22P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BRCA	PDYN →	+7.471	+0.016	.008	<.001	3	1
BRCA	NOP56 →	+7.471	+0.016	.008	<.001	3	1
BRCA	ASPN →	+8.471	+0.024	.005	<.001	3	1
BRCA	DPYSL3 →	+7.471	+0.016	.008	<.001	3	1
BRCA	TSKS →	+7.471	+0.016	.008	<.001	3	1
BRCA	PDE11A →	+7.471	+0.016	.008	<.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 33 associations by consensus.

Exploration

CDY22P survival (RNA) · tumor vs normal (RNA) · all CDY22P data types